<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02841501</url>
  </required_header>
  <id_info>
    <org_study_id>2011_63</org_study_id>
    <secondary_id>2012-A01344-39</secondary_id>
    <nct_id>NCT02841501</nct_id>
  </id_info>
  <brief_title>Genetic Susceptibility Factors for Candidemia.</brief_title>
  <official_title>Genetic Susceptibility Factors Involved in Candidemia: Case-control Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seventh Framework Programme</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Lausanne Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective case-control physiopathological study, which main objective is to
      determine the genetic host factors predisposing to candidemia. Secondary objectives are to
      develop new diagnosis tools using the biological collection, to describe and update
      epidemiology, to analyse the influence of genetic polymorphisms on prognosis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of the polymorphisms between the groups</measure>
    <time_frame>In the 48-72 hours following the positive blood culture</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Invasive Candidiasis</condition>
  <condition>Candidemia</condition>
  <condition>Genetic Predisposition to Disease</condition>
  <arm_group>
    <arm_group_label>Candidemia patients</arm_group_label>
    <description>These patients are included in the study after the reception of a positive blood culture for Candida sp.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control patients</arm_group_label>
    <description>These patients are matched on case patients on the following criteria:
Age+/-5 years
length of hospitalisation
type of ward
type of surgery for surgical patients
IGS2 for intensive care patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Analysis of genetic polymorphisms</intervention_name>
    <description>An analysis of the SNPs (single nucleotide polymorphism) of 25 candidate genes will be performed. This analysis will be completed by a genome wide association study.</description>
    <arm_group_label>Candidemia patients</arm_group_label>
    <arm_group_label>Control patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      20 mL of blood samples are collected at inclusion. 10 mL on EDTA tubes for the genetic
      analysis, and 1 mL on dry tube for biomarkers development.

      Paxgen tubes will be collected in a sample of patients for a transcriptomic study.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized patients exhibiting a positive blood culture with isolation of Candida sp.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient older than 18 years.

          -  Informed consent.

          -  Positive blood culture with isolation of Candida sp.

        Exclusion Criteria:

          -  No informed consent.

          -  Patient younger than 18.

          -  No insurance coverage.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien Poissy, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julien Poissy, MD, PhD</last_name>
    <email>julien.poissy@chru-lille.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pierre-Yves Bochud</last_name>
    <email>Pierre-Yves.Bochud@chuv.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>HÃ´pital Salengro, Intensive care departement, CHRU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Julien Poissy, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 20, 2016</study_first_submitted>
  <study_first_submitted_qc>July 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2016</study_first_posted>
  <last_update_submitted>January 17, 2017</last_update_submitted>
  <last_update_submitted_qc>January 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gene Expression Profiling</keyword>
  <keyword>Genome-Wide Association Study</keyword>
  <keyword>Polymorphism, Single Nucleotide</keyword>
  <keyword>Drug Resistance, Fungal</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Candidiasis</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Candidemia</mesh_term>
    <mesh_term>Candidiasis, Invasive</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

